黑客盯上生物科技

　　據紐約時報報道，為了獲取臨床試驗等相關信息，黑客們已經瞄準上市醫療和制藥公司的員工超過一年，這將影響全球市場。

　　網絡安全公司火眼（FireEye）報告了這個問題，受影響的公司中有一半屬于生物科技類的公司，但沒有披露受影響的公司清單。此外，根據報道FireEye稱這些黑客為“新一代”。

　　黑客的電子郵件內容很容易讓收件人上當，郵件非常精準的發給了每個受害者，運用完美的英語措辭謹慎的語句，使內容極像是有投行背景，并且具備相關行業知識的人寫的。

　　一旦公司管理人員點擊了黑客郵件中的鏈接或者打開了附件，都將會被引導到一個可以竊取他們信息的偽電子郵件登錄網站上。通過這種方式，黑客將可以讀取他們的電子郵件。

Hackers Target Biotechs

　　Hackers have been targeting the emails of publicly traded health care or pharmaceutical company employees for more than a year, trying to obtain information, such as clinical trial news, that could affect global markets, the New York Times reports.

　　The security firm reporting the breach, FireEye, didn't disclose the affected firms, but said half of them are in the biotechnology sector. Additionally, FireEye said these hackers appeared to represent "a new breed," according to the Times.

　　"Their email lures are precisely tailored toward each victim, written in flawless English and carefully worded to sound as if they were sent by someone with an extensive background in investment banking and with knowledge of the terms those in the industry employ," the Times says.

　　Some executives, it adds, have been drawn in and clicked on links or opened attachments to those emails, and were redirected to a fake email login site designed to steal their information. This way, the attackers could read their victim's email.

　　"Given the types of people they are targeting, they don't need to go into the environment； the senior roles they target have enough juicy information in their inbox," Jen Weedon, a FireEye threat intelligence manager, tells the Times. "They are after information protected by attorney-client privilege, safety reports, internal documents about investigations, and audits."